Oxford Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-294,379
| Closed | -$1.35M | – | 1632 |
|
|
2019
Q4 | $1.35M | Buy |
294,379
+1,173
| +0.4% | +$5.38K | 0.04% | 663 |
|
|
2019
Q3 | $1.14M | Sell |
293,206
-408
| -0.1% | -$1.58K | 0.03% | 874 |
|
|
2019
Q2 | $1.77M | Buy |
293,614
+108,766
| +59% | +$656K | 0.04% | 693 |
|
|
2019
Q1 | $2.48M | Sell |
184,848
-100,389
| -35% | -$1.35M | 0.05% | 469 |
|
|
2018
Q4 | $2.65M | Sell |
285,237
-11,102
| -4% | -$103K | 0.07% | 345 |
|
|
2018
Q3 | $4.13M | Buy |
296,339
+254,916
| +615% | +$3.55M | 0.09% | 284 |
|
|
2018
Q2 | $650K | Buy |
+41,423
| New | +$650K | 0.01% | 1234 |
|
|
2017
Q3 | – | Sell |
-10,565
| Closed | -$318K | – | 1782 |
|
|
2017
Q2 | $318K | Sell |
10,565
-26,796
| -72% | -$807K | 0.01% | 1245 |
|
|
2017
Q1 | $1.35M | Sell |
37,361
-31,465
| -46% | -$1.14M | 0.03% | 686 |
|
|
2016
Q4 | $3.45M | Buy |
68,826
+15,678
| +29% | +$786K | 0.12% | 166 |
|
|
2016
Q3 | $2.79M | Sell |
53,148
-51,054
| -49% | -$2.68M | 0.09% | 320 |
|
|
2016
Q2 | $4.31M | Sell |
104,202
-32,541
| -24% | -$1.35M | 0.14% | 179 |
|
|
2016
Q1 | $5.56M | Buy |
136,743
+106,901
| +358% | +$4.34M | 0.16% | 140 |
|
|
2015
Q4 | $1.24M | Buy |
+29,842
| New | +$1.24M | 0.03% | 484 |
|